Raffles PharmaTech Co., Ltd.

Established in August 2011, Raffles PharmaTech is a small molecule CDMO serving pharma innovators. We operate 2 Sites with more than 250 staff. Including a newly opened cGMP manufacturing site. Our clients include pharma and biotech organizations from across the globe. Including the US, EU, South Korea and China. We have a wide range of capabilities and offer specialty expertise in chiral compounds, Sulphur containing molecules, large scale organometallics and amino acid derivatives.